Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Strominger

Showing results (451-460 of 974) with videos related to

Pageof 98
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1992
Allelic variants of the human putative peptide transporter involved in antigen processingM Colonna, M Bresnahan, S Bahram, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2015
The HLA-G cycle provides for both NK tolerance and immunity at the maternal-fetal interfaceTamara Tilburgs, J Henry Evans, Ângela C Crespo, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 1998
Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptorsM Valés-Gómez, H T Reyburn, R A Erskine, et al.
Human Immunology|July 31, 2001
Synthetic peptides that inhibit binding of the myelin basic protein 85-99 epitope to multiple sclerosis-associated HLA-DR2 molecules and MBP-specific T-cell responsesM Fridkis-Hareli, J N Stern, L Fugger, et al.
Methods in Enzymology|January 1, 1984
Use of the HLA-DR antigens incorporated into liposomes to generate HLA-DR specific cytotoxic T lymphocytesJ C Gorga, J Foran, S J Burakoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 1997
Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding proteinS K Mahanta, T Scholl, F C Yang, et al.
Journal of Pediatric Ophthalmology and Strabismus|September 25, 2023
Management of Congenital EsotropiaRobert W Arnold, Mitchell B Strominger, Aldo Vagge, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1974
Heterogeneity of HL-A antigen preparations is due to variable sialic acid contentP Parham, R E Humphreys, M J Turner, et al.
Science (New York, N.Y.)|January 13, 1989
A new cluster of genes within the human major histocompatibility complexT Spies, G Blanck, M Bresnahan, et al.
The Journal of Biological Chemistry|August 10, 1974
Staphylococcal transfer ribonucleic acids. I. Isolation and purification of the isoaccepting glycine transfer ribonucleic acids from Staphylococcus epidermidis Texas 26R J Roberts, G G Lovinger, T Tamura, et al.
Pageof 98

Showing results (451-460 of 974) with videos related to

Sort By:
Pageof 98
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1992
Allelic variants of the human putative peptide transporter involved in antigen processingM Colonna, M Bresnahan, S Bahram, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 14, 2015
The HLA-G cycle provides for both NK tolerance and immunity at the maternal-fetal interfaceTamara Tilburgs, J Henry Evans, Ângela C Crespo, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 1998
Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptorsM Valés-Gómez, H T Reyburn, R A Erskine, et al.
Human Immunology|July 31, 2001
Synthetic peptides that inhibit binding of the myelin basic protein 85-99 epitope to multiple sclerosis-associated HLA-DR2 molecules and MBP-specific T-cell responsesM Fridkis-Hareli, J N Stern, L Fugger, et al.
Methods in Enzymology|January 1, 1984
Use of the HLA-DR antigens incorporated into liposomes to generate HLA-DR specific cytotoxic T lymphocytesJ C Gorga, J Foran, S J Burakoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 1997
Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding proteinS K Mahanta, T Scholl, F C Yang, et al.
Journal of Pediatric Ophthalmology and Strabismus|September 25, 2023
Management of Congenital EsotropiaRobert W Arnold, Mitchell B Strominger, Aldo Vagge, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1974
Heterogeneity of HL-A antigen preparations is due to variable sialic acid contentP Parham, R E Humphreys, M J Turner, et al.
Science (New York, N.Y.)|January 13, 1989
A new cluster of genes within the human major histocompatibility complexT Spies, G Blanck, M Bresnahan, et al.
The Journal of Biological Chemistry|August 10, 1974
Staphylococcal transfer ribonucleic acids. I. Isolation and purification of the isoaccepting glycine transfer ribonucleic acids from Staphylococcus epidermidis Texas 26R J Roberts, G G Lovinger, T Tamura, et al.
Pageof 98